FOLH1 and neoplasm: The study has several limitations; the detection of micrometastasis using bone marrow aspirations or biopsy has been documented although differing antibodies have been used to identify tumour cells, anti-cytokeratin, anti-PSA and anti-prostate specific membrane antigen (PSMA) for prostate cells.